COVID-19 monoclonal antibodies reduce risk of hospitalization and death ...Middle East

- News
COVID-19 monoclonal antibodies reduce risk of hospitalization and death
Monoclonal antibodies, a COVIDa-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication compared to similar patients who did not.

Hence then, the article about covid 19 monoclonal antibodies reduce risk of hospitalization and death was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( COVID-19 monoclonal antibodies reduce risk of hospitalization and death )

Apple Storegoogle play

Last updated :

Also on site :



Latest News